Milestone Pharmaceuticals News and Activities
Executives
View the org chart displaying its 21 main executives
Most searched biographies at Milestone Pharmaceuticals
- Joseph Oliveto, Director, President and Chief Executive Officer
- Lisa Giles, Independent Director
- Robert Wills, Chairman of the Board
Popular executive movements at Milestone Pharmaceuticals
- David Sandoval has joined the company as General Counsel and Chief Compliance Officer (posted on February 11 2026).
Create your alert
to follow the executive moves at Milestone Pharmaceuticals.
Pharmaceuticals
Milestone Pharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Milestone Pharmaceuticals
- Milestone Pharmaceuticals to Present at the Jefferies Healthcare Conference | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Corporate Update | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals Announces Presentation of Data from Phase 3 NODE-302 Study of Etripamil for the Treatment of PSVT | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals to Host Virtual Key Opinion Leader Event on Etripamil for the Treatment of PSVT | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical and Corporate Update | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals to Present at Upcoming Investor Conferences | Milestone Pharmaceuticals, Inc.
- Milestone Pharmaceuticals Announces Appointment of David Bharucha, M.D., Ph.D., as Chief Medical Officer | Milestone Pharmaceuticals, Inc.
- View more press releases Close
Social media about Milestone Pharmaceuticals
- Milestone Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Milestone Pharmaceuticals on LinkedIn, X (Twitter) & YouTube
